BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 29
• 30

• BioMidwest

  Medtronic, Inc. Release: Data from Pivotal Study Show Medtronic Deep Brain Stimulation Therapy Reduced Seizure Rate in Patients with Severe Epilepsy

  December 8, 2008

   · 

  1 min read
• Pharm Country

  Eli Lilly and Company And Bristol-Myers Squibb Company Release: ERBITUX(R) Supplemental Biologics License Application for Advanced Non-Small Cell Lung Cancer Submitted to U.S. FDA

  December 8, 2008

   · 

  1 min read
• Deals

  bioMerieux SA Acquires Culture Media Specialist PML Microbiologicals, Inc. Reinforcing Position in the North American Microbiology Market

  December 8, 2008

   · 

  1 min read
• Celgene International Sárl Release: Two ASH Presentations Report REVLIMID(R) Activity and Tolerability in Patients with Previously Untreated Symptomatic Chronic Lymphocytic Leukemia

  December 8, 2008

   · 

  1 min read
• Drug Development

  GlycoMimetics, Inc. to Present New Results of Lead Candidate in Additional Animal Models of Sickle Cell Disease at American Society of Hematology Annual Meeting

  December 8, 2008

   · 

  1 min read
• BioCapital

  Emergent BioSolutions to Webcast Presentation at the J.P. Morgan 27th Annual Healthcare Conference on Wednesday, January 14, 2009

  December 8, 2008

   · 

  1 min read
• Biotech Bay

  Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Release: Rivaroxaban Reduces Symptomatic VTE & Death Following Knee or Hip Replacement Surgery by More Than 50% Compared to Enoxaparin in Pooled Analysis of the RECORD Clinical Trial Progra

  December 8, 2008

   · 

  1 min read
• Drug Development

  GPC Biotech AG Announces Presentation of New Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor at the American Society of Hematology Annual Meeting

  December 8, 2008

   · 

  1 min read
• Business

  ImmunoGen, Inc. Announces Genentech, Inc.’s Fifth TAP Technology License

  December 8, 2008

   · 

  1 min read
• Drug Development

  Incyte Corporation’s Selective JAK1 / 2 Inhibitor, INCB18424, Demonstrates Rapid and Durable Clinical Benefits in Myelofibrosis Patients

  December 8, 2008

   · 

  1 min read